JP Morgan Upgrades Grupo Cibest to Overweight, Raises Price Target to $110

Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks

With bond yields declining and Social Security concerns mounting, retirees are turning to dividend-paying stocks as an alternative income source. The article recommends investing in high-quality dividend stocks with consistent dividend growth histories to combat inflation and supplement retirement income, while cautioning against high-fee mutual funds and ETFs.

Beat the Market the Zacks Way: FIGS, Microsoft, Amphenol in Focus

Zacks Investment Research showcases the performance of its various stock rating systems and portfolios. The Zacks Rank #1 portfolio outperformed the S&P 500 by 2.3 percentage points year-to-date, while individual stocks like FIGS and CRL surged following rank upgrades. The Focus List, ECAP, ECDP, and Top 10 portfolios also demonstrated strong returns, with the Top 10 portfolio delivering a cumulative return of +2,881.3% since 2012 compared to the S&P 500's +648.5%.

Goldman Sachs Maintains Buy on Grupo Cibest, Raises Price Target to $110

Goldman Sachs analyst Tito Labarta maintains Grupo Cibest (NYSE:CIB) with a Buy and raises the price target from $98 to $110.

Grupo Cibest shares are trading higher after JP Morgan upgraded the stock from Neutral to Overweight and raised its price target from $70 to $110.